Difference between revisions of "Polymorphous adenocarcinoma"

Jump to navigation Jump to search
m (Michael moved page Polymorphous low-grade adenocarcinoma to Polymorphous adenocarcinoma: renamed https://pubmed.ncbi.nlm.nih.gov/29761209/)
 
(12 intermediate revisions by the same user not shown)
Line 3: Line 3:
| Image      = Polymorphous_low-grade_adenocarcinoma_high_mag.jpg
| Image      = Polymorphous_low-grade_adenocarcinoma_high_mag.jpg
| Width      =
| Width      =
| Caption    = PLGA. [[H&E stain]].
| Caption    = Polymorphous adenocarcinoma. [[H&E stain]].
| Synonyms  = polymorphmous low-grade adenocarcinoma (obsolete term)
| Micro      = low-grade cytology - nuclei ovoid & small, small nucleoli, powdery chromatin ([[papillary thyroid carcinoma]]-like appearance); eosinophilic cytoplasm; variable architecture - often small nests, classically has whorling ("eye-of-storm") pattern and single file pattern  
| Micro      = low-grade cytology - nuclei ovoid & small, small nucleoli, powdery chromatin ([[papillary thyroid carcinoma]]-like appearance); eosinophilic cytoplasm; variable architecture - often small nests, classically has whorling ("eye-of-storm") pattern and single file pattern  
| Subtypes  =
| Subtypes  =
| LMDDx      = [[adenoid cystic carcinoma]], [[pleomorphic adenoma]], [[cribriform adenocarcinoma of the minor salivary gland]]
| LMDDx      = [[adenoid cystic carcinoma]], [[pleomorphic adenoma]], [[cribriform adenocarcinoma of the minor salivary gland]]
| Stains    =
| Stains    =
| IHC        = S-100 +ve, CK7 +ve, vimentin +ve
| IHC        = S-100 +ve, CK7 +ve, p40 -ve, p63 +ve, vimentin +ve
| EM        =
| EM        =
| Molecular  =
| Molecular  =
Line 28: Line 29:
| ClinDDx    =
| ClinDDx    =
}}
}}
'''Polymorphous low-grade adenocarcinoma''', abbreviated '''PLGA''', is a rare malignant [[salivary gland]] tumour.
'''Polymorphous adenocarcinoma''', abbreviated '''PAC''', is a rare malignant [[salivary gland]] tumour.
 
It was previously known as '''polymorphous low-grade adenocarcinoma''', abbreviated '''PLGA'''.<ref name=pmid29761209>{{cite journal |authors=Vander Poorten V, Triantafyllou A, Skálová A, Stenman G, Bishop JA, Hauben E, Hunt JL, Hellquist H, Feys S, De Bree R, Mäkitie AA, Quer M, Strojan P, Guntinas-Lichius O, Rinaldo A, Ferlito A |title=Polymorphous adenocarcinoma of the salivary glands: reappraisal and update |journal=Eur Arch Otorhinolaryngol |volume=275 |issue=7 |pages=1681–1695 |date=July 2018 |pmid=29761209 |doi=10.1007/s00405-018-4985-5 |url=}}</ref>


==General==
==General==
Line 51: Line 54:


Note:
Note:
*'''Always''' a low-grade tumour - by definition.
*''Pretty much always'' a low-grade tumour.


DDx:
DDx:
*[[Adenoid cystic carcinoma]].
*[[Adenoid cystic carcinoma]].
*[[Pleomorphic adenoma]].
*[[Pleomorphic adenoma]].
*[[Cribriform adenocarcinoma of the minor salivary gland]].<ref name=pmid21716087>{{Cite journal | last1 = Skalova | first1 = A. | last2 = Sima | first2 = R. | last3 = Kaspirkova-Nemcova | first3 = J. | last4 = Simpson | first4 = RH. | last5 = Elmberger | first5 = G. | last6 = Leivo | first6 = I. | last7 = Di Palma | first7 = S. | last8 = Jirasek | first8 = T. | last9 = Gnepp | first9 = DR. | title = Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. | journal = Am J Surg Pathol | volume = 35 | issue = 8 | pages = 1168-76 | month = Aug | year = 2011 | doi = 10.1097/PAS.0b013e31821e1f54 | PMID = 21716087 }}
*[[Cribriform adenocarcinoma of the minor salivary gland]] - if one considers it a separate diagnosis.
</ref>
**The ''World Health Organization'' lumps ''[[cribriform adenocarcinoma of the minor salivary gland]]'' with ''polymorphous adenocarcinoma''.<ref name=pmid29761209>{{cite journal |authors=Vander Poorten V, Triantafyllou A, Skálová A, Stenman G, Bishop JA, Hauben E, Hunt JL, Hellquist H, Feys S, De Bree R, Mäkitie AA, Quer M, Strojan P, Guntinas-Lichius O, Rinaldo A, Ferlito A |title=Polymorphous adenocarcinoma of the salivary glands: reappraisal and update |journal=Eur Arch Otorhinolaryngol |volume=275 |issue=7 |pages=1681–1695 |date=July 2018 |pmid=29761209 |doi=10.1007/s00405-018-4985-5 |url=}}</ref>
 
===Images===
===Images===
<gallery>
<gallery>
Line 70: Line 72:
*CK7 +ve.
*CK7 +ve.
*Vimentin +ve.
*Vimentin +ve.
*p63 +ve (22 of 23 cases<ref name=pmid31653135/>).
*p40 -ve (22 of 23 cases<ref name=pmid31653135>{{cite journal |authors=Atiq A, Mushtaq S, Hassan U, Loya A, Hussain M, Akhter N |title=Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |journal=Asian Pac J Cancer Prev |volume=20 |issue=10 |pages=2917–2921 |date=October 2019 |pmid=31653135 |pmc=6982655 |doi=10.31557/APJCP.2019.20.10.2917 |url=}}</ref>).
**Useful to differentiate from [[adenoid cystic carcinoma]] (AdCC); AdCC is usually p63 +ve/p40 +ve (36 or 47 cases) or p63 -ve/p40 -ve (10 of 47 cases).


Others:
Others:
Line 81: Line 86:


==References==
==References==
{{Reflist|1}}
{{Reflist|2}}


[[Category:Diagnosis]]
[[Category:Diagnosis]]
[[Category:Salivary gland]]
[[Category:Salivary gland]]
48,466

edits

Navigation menu